But compared to ovarian cancer, the sensitivity and specificity of CA125 in diagnosing endometrial cancer are lower; hence it is only suitable for patients with advanced endometrial cancer or recurrent endometrial cancer. This evidence concerns the gene MUC16 and ovarian carcinoma.